IP Library Granted Patent US 8,901,109
Granted Patent B2
US 8,901,109 · App. 12/821,287 · Granted Dec 2, 2014

Quercetin-containing compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,901,109
App. No.
12/821,287
Granted
Dec 2, 2014
Kind
B2
Abstract

This invention relates to a composition containing quercetin, vitamin B3, vitamin C, and folic acid. Also disclosed is a method of using the composition for enhancing physical or mental performance or treating various diseases or disorders.

Claims (22)

1. A method for treating a disease or disorder, comprising administering to a subject in need thereof an effective amount of a composition consisting essentially of quercetin, vitamin B3, vitamin C, and folic acid; wherein the disease or disorder is thyroiditis, rheumatoid arthritis, myositis, lupus, Celiac disease, eczema, urticaria, psoriasis, asthma, pulmonary fibrosis, chronic obstructive pulmonary disease, prostatitis, Crohn's disease, ulcerative colitis, arthritis, leukemia, colon cancer, prostate cancer, kidney cancer, liver cancer, breast cancer, lung cancer, type II diabetes, sexual dysfunction, chronic constipation, influenza, human immunodeficiency virus infection, or herpes simplex virus infection.

2. The method of claim 1 , wherein a weight ratio between quercetin, vitamin B3, and vitamin C is 1: 0.02-1: 0.2-2.5.

3. The method of claim 2 , wherein the weight ratio is 1: 0.05-0.2: 0.5-1.

4. The method of claim 2 , wherein the weight ratio is 1: 0.1-0.2: 0.5-1.

5. The method of claim 2 , wherein the weight ratio is 1: 0.04: 1.

6. The method of claim 2 , wherein the weight ratio is 1: 0.08: 1.

7. The method of claim 1 , wherein the composition is in dry form.

8. The method of claim 7 , wherein a weight ratio between quercetin, vitamin B3, and vitamin C is 1: 0.02-1: 0.2-2.5.

9. The method of claim 8 , wherein the weight ratio is 1: 0.05-0.2: 0.5-1.

10. The method of claim 8 , wherein the weight ratio is 1: 0.1-0.2: 0.5-1.

11. The method of claim 8 , wherein the weight ratio is 1: 0.04: 1.

12. The method of claim 8 , wherein the weight ratio is 1: 0.08: 1.

13. The method of claim 1 , wherein the composition is in liquid form.

14. The method of claim 13 , wherein a weight ratio between quercetin, vitamin B3, and vitamin C is 1: 0.02-1: 0.2-2.5.

15. The method of claim 14 , wherein the weight ratio is 1: 0.05-0.2: 0.5-1.

16. The method of claim 14 , wherein the weight ratio is 1: 0.1-0.2: 0.5-1.

17. The method of claim 14 , wherein the weight ratio is 1: 0.04: 1.

18. The method of claim 14 , wherein the weight ratio is 1: 0.08: 1.

19. The method of claim 1 , wherein the composition is a food product.

20. The method of claim 19 , wherein the food product is tea, soft drinks, juice, milk, coffee, jelly, ice cream, yogurt, cookies, cereals, chocolates, or snack bars.

21. The method of claim 1 , wherein the composition is a dietary supplement or a pharmaceutical formulation.

22. The method of claim 21 , wherein the composition is a tablet, a capsule, a soft chew, or a gel.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: QUERCEGEN PHARMA A.G.
To: LINES, THOMAS CHRISTIAN
Reel/Frame 052151/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: LINES, THOMAS CHRISTIAN
To: QUERCIS PHARMA A.G.
Reel/Frame 052153/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2020
From: LINES, THOMAS; QUERCEGEN PHARMA LLC; QUERCEGEN PHARMA LLP; QUERCEGEN TECHNOLOGIES; QUERCEGEN PHARMACEUTICALS, LLC; QUERCEGEN HOLDINGS, LLC; NEW SUN NUTRITION, LLC; THE FRS COMPANY
To: QUERCEGEN PHARMA, AG.
Reel/Frame 052110/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2013
From: LINES, THOMAS CHRISTIAN
To: QUERCEGEN PHARMA LLC
Reel/Frame 029838/0191 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2013
From: QUERCEGEN PHARMA LLC
To: QUERCEGEN PHARMACEUTICALS LLC
Reel/Frame 029838/0288 →